Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Marquette National Corporation Reports First Quarter 2026 Results
-
Form 8.5 (EPT/RI)-NCC Group plc
-
ISS signs agreement to acquire Tomagruppen
-
Holding(s) in Company
-
Most Vision Loss Is Preventable—20+ Eye Care, Neurology and Integrative Medicine Experts Unite for Free Global Summit This May
-
Dividend payment ex-date of Aktsiaselts Tallinna Vesi
-
Umbrella Lab Announces Documentation And Traceability Update For DSIP Peptide
-
The continuing business realised revenue of DKK 263.3 million compared to DKK 261.5 million in the same period last year. Operating profit (EBIT) was DKK 22.7 million comapred to DKK 20.9 million in t
-
Landsbankinn hf.: Offering of covered bonds
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Ltd
-
match.asia Introduces AI-Enabled Platform to Unlock Cross-Border M&A for SMEs
-
match.asia Introduces AI-Enabled Platform to Unlock Cross-Border M&A for SMEs
-
GEN Korean BBQ Launches Costco Roadshow Series, Marking Next Phase of Retail Expansion
-
ESET Research uncovers CallPhantom scam on Google Play: Fake logs for real money
-
Himax Technologies, Inc. Declares Cash Dividend for FY2025
-
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Transactions by persons discharging managerial responsibilities and persons closely associated with them
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Other World Computing (OWC) Expands UK Channel with M2M Direct Distribution Partnership
-
StepStone Launches Evergreen Strategies on LSEG’s Digital Markets Infrastructure (DMI)
-
Virbac : Declaration of the number of shares and voting rights 04/2026
-
Scarlet Therapeutics Demonstrates In Vivo Survival of Lab-Grown Universal Red Blood Cells Equivalent to Donated Blood
-
Pakistan’s HBL Goes live on Temenos Core Banking
-
Shapermint Completes Five-Month, Three-Episode Partnership with SHERRI, Celebrating Confidence and Comfort Through Mother's Day
-
HOMEVI pre Stabilization Notice
-
Shapermint Completes Five-Month, Three-Episode Partnership with SHERRI, Celebrating Confidence and Comfort Through Mother's Day
-
PRE ANNOUNCEMENT OF CERTIFICATE AUCTION TENDER
-
ViaNautis Bio to present its targeted polyNaut® nanovesicles (tPNVs) for the generation of in vivo CAR-T therapies at ASGCT Annual Meeting
-
Temenos Launches Embedded AI Capabilities to Help Banks Move Faster, Stay in Control, and Create Better Experiences
-
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
-
Valeo - Voting rights - April 2026
-
Replacement in bonds for new lending - Nykredit Realkredit A/S
-
Apollo Funds Complete Acquisition of Prosol Group
-
Ashley Graham to Spotlight the Power of Authentic Partnerships as a Keynote Speaker at Licensing Expo 2026
-
Telko to reorganize its operations into two business units
-
LinkedIn partners with the Digital Vending Machine® from Bango to expand Premium reach through bundling
-
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.
-
The decision of the management company of INVL Technology on the purchase of own shares
-
Suominen Corporation’s Interim Report for January 1 – March 31, 2026: Profitability improvement program underway
-
Michelin: Disclosure of trading in own shares - May 7th, 2026
-
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
-
BAE Systems – Trading update
-
Financial Calendar 2026 - update
-
Shell announces commencement of a share buyback programme
-
Shell announces commencement of a share buyback programme
-
Shell plc First Quarter 2026 Interim Dividend
-
Shell plc publishes first quarter 2026 press release

